Zacks Research Brokers Boost Earnings Estimates for MRSH

Key Points

• Zacks Research nudged up its Q3 2026 EPS estimate for Marsh & McLennan to $1.97 (from $1.96) and issued forward forecasts including FY2028 EPS of $11.93, reflecting modest upward earnings revisions.
• Analyst sentiment is mixed with a consensus rating of "Hold" and a $205.33 target; the company recently beat Q1 EPS expectations ($3.29 vs. $3.21) and announced a $0.90 quarterly dividend (annualized $3.60, ~2.2% yield).

Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) - Research analysts at Zacks Research lifted their Q3 2026 earnings per share estimates for shares of Marsh & McLennan Companies in a note issued to investors on Thursday, April 30th. Zacks Research analyst Team now forecasts that the financial services provider will post earnings per share of $1.97 for the quarter, up from their prior estimate of $1.96. The consensus estimate for Marsh & McLennan Companies' current full-year earnings is $10.36 per share. Zacks Research also issued estimates for Marsh & McLennan Companies' Q4 2026 earnings at $2.18 EPS, Q2 2027 earnings at $2.90 EPS and FY2028 earnings at $11.93 EPS.

A number of other analysts also recently weighed in on MRSH. Raymond James Financial upgraded Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 target price for the company in a research report on Tuesday, February 17th. Morgan Stanley decreased their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating on the stock in a research note on Monday, April 6th. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a $200.00 price target on shares of Marsh & McLennan Companies in a research note on Friday, January 30th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Marsh & McLennan Companies in a research note on Monday, April 27th. Finally, Evercore decreased their price target on Marsh & McLennan Companies from $237.00 to $236.00 and set an "outperform" rating on the stock in a research note on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $205.33.

Marsh & McLennan Companies Price Performance

NYSE:MRSH opened at $166.38 on Friday. The stock has a 50 day moving average price of $173.42. The company has a market cap of $80.16 billion, a P/E ratio of 20.80, a price-to-earnings-growth ratio of 2.42 and a beta of 0.65. Marsh & McLennan Companies has a 1-year low of $164.89 and a 1-year high of $235.78. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping analysts' consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business's revenue for the quarter was up 7.6% on a year-over-year basis.

Marsh & McLennan Companies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Thursday, April 9th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, April 9th. This represents a $3.60 annualized dividend and a dividend yield of 2.2%. Marsh & McLennan Companies's payout ratio is 45.00%.

Insider Activity

In other news, CEO John Q. Doyle sold 16,655 shares of the business's stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares of the company's stock, valued at approximately $21,411,456.30. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.38% of the company's stock.

Institutional Investors Weigh In On Marsh & McLennan Companies

Several hedge funds have recently added to or reduced their stakes in MRSH. Brighton Jones LLC boosted its holdings in Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock worth $1,856,000 after acquiring an additional 2,960 shares in the last quarter. Bison Wealth LLC increased its position in Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock valued at $651,000 after acquiring an additional 869 shares during the last quarter. Glenview Trust co increased its position in Marsh & McLennan Companies by 10.8% during the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock valued at $852,000 after acquiring an additional 379 shares during the last quarter. Osterweis Capital Management Inc. increased its position in Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock valued at $203,000 after acquiring an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC purchased a new stake in Marsh & McLennan Companies during the second quarter valued at $1,307,000. 87.99% of the stock is owned by institutional investors.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.